Metabolic effects of psychotropic drugs [volume editors] J. Thakore, B.E. Leonard
Material type: TextSeries: Modern Trends in Pharmacopsychiatry ; 26Publication details: London Karger 2009Description: viii, 133 pISBN:- 9783805590013
- 615.788
Item type | Current library | Home library | Shelving location | Call number | Copy number | Status | Date due | Barcode | Item holds | |
---|---|---|---|---|---|---|---|---|---|---|
4 Week Loan | St. Luke's General Hospital Kilkenny | St. Luke's General Hospital Kilkenny | Open Shelves | 616.8918 (Browse shelf(Opens below)) | 1 | Available | 031227 |
Includes bibliographical references and index
Preface; Metabolic Syndrome and Schizophrenia: Is Inflammation the Cause? Leonard, B.E.; Insulin Resistance in Bipolar Women: Effects of Mood-Stabilizing Drugs: Vermuri, M.; Stemmle, P.; Jiang, B.; Morenkova, A.; Rasgon, N.; Obesity and Mental Illness: Citrome, L.; Vreeland, B.; Glucose Abnormalities in Schiophrenia, Bipolar and Major Depressive Disorders: Bushe, C.; Screening for Diabetes and Cardiovascular Risk Factors in People with Serious Mental Illness: Holt, R.I.G.; Peveler, R.C.; Stress Anxis Dysfunction: A Common Finding in Schizophrenia and the Metabolic Syndrome?: Afzal, A.; Thakore, J.; Metabolic Syndrome in Psychiatic Inpatients Treated for Depression: Goethe, J.W.; Szarek, B.L.; Caley, C.F.; Hyperprolactinaemia Associated with Antipsychotic Medications: Fitzgerald, P.; Dinan, T.G.; Impact of Hyperprolactinaemia on the General Health of Patients with Schizophrenia: Wildgust, H.J.; Kohen, D.; Autor Index; Subject Index.
1
There are no comments on this title.